90 related articles for article (PubMed ID: 25696931)
1. [Immunoassay of nine serological tumor markers on hydrogel-based microchip].
Zubcova ZhI; Savvateeva EN; Butvilovskaia VI; Cybul'skaia MV; Chechetkin VR; Samokhina LO; Vinnitskiĭ LI; Maslennikov VV; Reznikov IuP; Zasedatelev AS; Rubina AIu
Bioorg Khim; 2013; 39(6):693-704. PubMed ID: 25696931
[TBL] [Abstract][Full Text] [Related]
2. Multiplex determination of serological signatures in the sera of colorectal cancer patients using hydrogel biochips.
Butvilovskaya VI; Popletaeva SB; Chechetkin VR; Zubtsova ZI; Tsybulskaya MV; Samokhina LO; Vinnitskii LI; Ragimov AA; Pozharitskaya EI; Grigor Eva GA; Meshalkina NY; Golysheva SV; Shilova NV; Bovin NV; Zasedatelev AS; Rubina AY
Cancer Med; 2016 Jul; 5(7):1361-72. PubMed ID: 26992329
[TBL] [Abstract][Full Text] [Related]
3. Biological microchip for a simultaneous quantitative immunoassay of tumor markers in human serum.
Savvateeva EN; Dementieva EI; Tsybulskaya MV; Osipova TV; Ryabykh TP; Turygin AY; Yurasov RA; Zasedatelev AS; Rubina AY
Bull Exp Biol Med; 2009 Jun; 147(6):737-41. PubMed ID: 19902071
[TBL] [Abstract][Full Text] [Related]
4. [Development of a biochip for quantitative determination of two forms of prostate specific antigen using internal calibration curve].
Konovalova EV; Savvateeva EN; Dement'eva EI; Filippova MA; Turygin AIu; Osipova TV; Riabykh TP; Rubina AIu; Zasedatelev AS
Mol Biol (Mosk); 2007; 41(4):734-8. PubMed ID: 17936996
[TBL] [Abstract][Full Text] [Related]
5. Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases.
Chen C; Chen LQ; Yang GL; Li Y
Ai Zheng; 2007 Nov; 26(11):1221-6. PubMed ID: 17991322
[TBL] [Abstract][Full Text] [Related]
6. CEA, CA 242, CA 19-9, CA 72-4 and hCGbeta in the diagnosis of recurrent colorectal cancer.
Carpelan-Holmström M; Louhimo J; Stenman UH; Alfthan H; Järvinen H; Haglund C
Tumour Biol; 2004; 25(5-6):228-34. PubMed ID: 15627885
[TBL] [Abstract][Full Text] [Related]
7. [Hydrogel microchip as a tool for studying exosomes in human serum].
Butvilovskaya VI; Tikhonov AA; Savvateeva EN; Ragimov AA; Salimov EL; Voloshin SA; Sidorov DV; Chernichenko MA; Polyakov AP; Filushin MM; Tsybulskaya MV; Rubina AY
Mol Biol (Mosk); 2017; 51(5):817-823. PubMed ID: 29116068
[TBL] [Abstract][Full Text] [Related]
8. Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers.
Dolscheid-Pommerich RC; Keyver-Paik M; Hecking T; Kuhn W; Hartmann G; Stoffel-Wagner B; Holdenrieder S
Tumour Biol; 2017 Oct; 39(10):1010428317730246. PubMed ID: 29034816
[TBL] [Abstract][Full Text] [Related]
9. Estimating the probability of cancer with several tumor markers in patients with colorectal disease.
Carpelan-Holmström M; Louhimo J; Stenman UH; Alfthan H; Järvinen H; Haglund C
Oncology; 2004; 66(4):296-302. PubMed ID: 15218297
[TBL] [Abstract][Full Text] [Related]
10. The evaluation of diagnostic value of the tumor markers: CCSA-2 and CEA in colorectal cancer.
Knychalski B; Lukieńczuk T
Pol Przegl Chir; 2012 Feb; 84(2):86-92. PubMed ID: 22487741
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic growth factors in colorectal cancer patients.
Mroczko B; Szmitkowski M; Okulczyk B
Clin Chem Lab Med; 2003 May; 41(5):646-51. PubMed ID: 12812262
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of tumor markers biochip C12 system in the diagnosis of gastric cancer and the strategies for improvement: analysis of 100 cases.
Chen C; Chen LQ; Chen LD; Yang GL; Li Y
Hepatogastroenterology; 2008; 55(84):991-7. PubMed ID: 18705314
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma.
Zhang SY; Lin M; Zhang HB
Int J Clin Exp Pathol; 2015; 8(8):9404-9. PubMed ID: 26464695
[TBL] [Abstract][Full Text] [Related]
14. Development of antibody functionalized magnetic nanoparticles for the immunoassay of carcinoembryonic antigen: a feasibility study for clinical use.
Yang CC; Yang SY; Ho CS; Chang JF; Liu BH; Huang KW
J Nanobiotechnology; 2014 Nov; 12():44. PubMed ID: 25424410
[TBL] [Abstract][Full Text] [Related]
15. Normal and modified urinary nucleosides represent novel biomarkers for colorectal cancer diagnosis and surgery monitoring.
Feng B; Zheng MH; Zheng YF; Lu AG; Li JW; Wang ML; Ma JJ; Xu GW; Liu BY; Zhu ZG
J Gastroenterol Hepatol; 2005 Dec; 20(12):1913-9. PubMed ID: 16336453
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of carcinoembryonic antigen (CEA), epidermal growth factor receptor (EGFR), epithelial cell adhesion molecule EpCAM (GA733-2), and carbohydrate antigen 19-9 (CA 19-9) levels in colorectal cancer patients and correlation with clinicopathological characteristics.
Mourtzikou A; Stamouli M; Kroupis C; Christodoulou S; Skondra M; Kastania A; Pectasides D; Athanasas G; Dimas C
Clin Lab; 2012; 58(5-6):441-8. PubMed ID: 22783573
[TBL] [Abstract][Full Text] [Related]
17. A system for tumor heterogeneity evaluation and diagnosis based on tumor markers measured routinely in the laboratory.
Hui L; Rixv L; Xiuying Z
Clin Biochem; 2015 Dec; 48(18):1241-5. PubMed ID: 26216289
[TBL] [Abstract][Full Text] [Related]
18. Serum HCG beta, CA 72-4 and CEA are independent prognostic factors in colorectal cancer.
Louhimo J; Carpelan-Holmström M; Alfthan H; Stenman UH; Järvinen HJ; Haglund C
Int J Cancer; 2002 Oct; 101(6):545-8. PubMed ID: 12237895
[TBL] [Abstract][Full Text] [Related]
19. Granulocyte-colony stimulating factor (G-CSF) and macrophagecolony stimulating factor (M-CSF) in colorectal cancer patients.
Mroczko B; Szmitkowski M; Okulczyk B
Clin Chem Lab Med; 2002 Apr; 40(4):351-5. PubMed ID: 12059074
[TBL] [Abstract][Full Text] [Related]
20. [Application of multiple tumor markers's protein chip in the screen program of the elderly].
Yan HY; Zhong RH; Li J; Luo XH; Chen R
Zhonghua Liu Xing Bing Xue Za Zhi; 2011 Sep; 32(9):924-6. PubMed ID: 22340884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
